Symbol="AUTL"
AssetType="Common Stock"
Name="Autolus Therapeutics Ltd"
Description="Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T-cell therapies for the treatment of cancer. The company is headquartered in London, the United Kingdom."
CIK="1730463"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="FOREST HOUSE, 58 WOOD LANE, WHITE CITY, LONDON, GB"
FiscalYearEnd="September"
LatestQuarter="2023-03-31"
MarketCapitalization="427280000"
EBITDA="-157894000"
PERatio="None"
PEGRatio="None"
BookValue="1.542"
DividendPerShare="0"
DividendYield="0"
EPS="-1.37"
RevenuePerShareTTM="0.065"
ProfitMargin="0"
OperatingMarginTTM="-22.05"
ReturnOnAssetsTTM="-0.25"
ReturnOnEquityTTM="-0.564"
RevenueTTM="7486000"
GrossProfitTTM="-130860000"
DilutedEPSTTM="-1.37"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="6.78"
AnalystTargetPrice="7.31"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="62.1"
PriceToBookRatio="1.046"
EVToRevenue="6.47"
EVToEBITDA="-0.118"
Beta="1.473"
num_52WeekHigh="3.79"
num_52WeekLow="1.6"
num_50DayMovingAverage="2.63"
num_200DayMovingAverage="2.294"
SharesOutstanding="173691000"
DividendDate="None"
ExDividendDate="None"
symbol="AUTL"
open="2.51"
high="2.59"
low="2.39"
price="2.46"
volume="260942.00"
latest_trading_day="2023-07-14"
previous_close="2.52"
change="-0.06"
change_percent="-2.3810%"
aroon_positive_momentum_days="55"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="55"
Volume_recent_avg="610808"
Change_recent_avg="0.01"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.32"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="55"
Aroon_momentum_negative="45"
image_negative_thumbnail_id_1="150"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0026.jpeg"
image_negative_thumbnail_id_2="1092"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0125.jpeg"
image_neutral_thumbnail_id_1="568"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_neutral_thumbnail_id_2="557"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_positive_thumbnail_id_1="676"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0032.jpeg"
image_positive_thumbnail_id_2="672"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0036.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
